The Rutgers School of Law–Newark Second Annual Pharmaceutical Patent Law Panel will take place on Monday, November 12, from 4 – 6 pm in the Baker Trial Courtroom. “Perspectives from Industry” will feature current and former in-house lawyers from leading pharmaceutical companies. The panel will be moderated by Adjunct Professors Nicholas Groombridge, a partner and co-chair of the patent litigation practice at Weil, Gotshal & Manges LLP, and Sandra A. Bresnick, a partner in the intellectual property practice at Sidley Austin LLP. Groombridge and Bresnick co-teach “Pharmaceutical Patent Law” at Rutgers.

Following is the agenda:

4 – 5 pm Panel:

• Current State of Affairs in the Pharma Industry
• Life Cycle Management and Patent Portfolio Management
  • o Key risk concepts
  • Product development and patenting in view of: the U.S. Supreme Court’s KSR decision; the new U.S. Patent and Trademark Office rules (and Glaxo Group Limited’s preliminary injunction); the MMA 
  • Strategies for early-stage and late-stage products

Break

5:10-6:10 pm Panel: 

• Litigation Strategies and Risks
  • Emerging trends
  • At-risk launches
  • Branded and generic pharmaceutical patent settlements
• Pharma Patent Litigation in Other Jurisdictions
  • Hatch-Waxman style litigation elsewhere in the world
  • The outlook for enforcing pharma patents in China, India and other developing countries
• Where the Industry Is Headed
  • Views of current legislation